Arrowhead Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARWR and other ETFs, options, and stocks.About ARWR
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC.
CEOChristopher Richard Anzalone
CEOChristopher Richard Anzalone
Employees711
Employees711
HeadquartersPasadena, California
HeadquartersPasadena, California
Founded1989
Founded1989
Employees711
Employees711
ARWR Key Statistics
Market cap8.80B
Market cap8.80B
Price-Earnings ratio-964.29
Price-Earnings ratio-964.29
Dividend yield—
Dividend yield—
Average volume3.40M
Average volume3.40M
High today—
High today—
Low today—
Low today—
Open price$65.99
Open price$65.99
Volume0.00
Volume0.00
52 Week high$72.36
52 Week high$72.36
52 Week low$9.57
52 Week low$9.57
Stock Snapshot
With a market cap of 8.8B, Arrowhead Pharmaceuticals(ARWR) trades at $64.43. The stock has a price-to-earnings ratio of -964.29.
Arrowhead Pharmaceuticals(ARWR) stock opened on 2025-12-18 at $65.99. The price climbed to — and dipped to —.
Arrowhead Pharmaceuticals(ARWR) shares are trading with a volume of 0, against a daily average of 3.4M.
In the last year, Arrowhead Pharmaceuticals(ARWR) shares hit a 52-week high of $72.36 and a 52-week low of $9.57.
In the last year, Arrowhead Pharmaceuticals(ARWR) shares hit a 52-week high of $72.36 and a 52-week low of $9.57.
ARWR News
TipRanks 1d
Arrowhead Pharmaceuticals CEO Makes a Multi-Million Dollar Stock Sale!New insider activity at Arrowhead Pharmaceuticals ( (ARWR) ) has taken place on December 16, 2025. Claim 50% Off TipRanks Premium and Invest with Confidence Unl...
Analyst ratings
64%
of 14 ratingsBuy
64.3%
Hold
35.7%
Sell
0%
People also own
Based on the portfolios of people who own ARWR. This list is generated using Robinhood data, and it’s not a recommendation.